Ticker
IOVACompany Name
IOVANCE BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Total Debt | Debt to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 907.44M | $ 53.17M | 5.86% |
3/31/2025 | $ 966.74M | $ 53.72M | 5.56% |
12/31/2024 | $ 910.43M | $ 58.26M | 6.4% |
9/30/2024 | $ 991.12M | $ 78.94M | 7.96% |
6/30/2024 | $ 964.32M | $ 81.68M | 8.47% |
3/31/2024 | $ 869.83M | $ 84.37M | 9.7% |
12/31/2023 | $ 780.35M | $ 75.86M | 9.72% |
9/30/2023 | $ 852.32M | $ 79.48M | 9.32% |
6/30/2023 | $ 757.29M | $ 80.71M | 10.66% |
3/31/2023 | $ 824.77M | $ 83.23M | 10.09% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Debt / Assets
(=) Debt to Assets
Debt to Assets for IOVANCE BIOTHERAPEUTICS INC is calculated as follows: Debt [ $ 10.91M ] / Assets [ $ 782.29M ]
(=) Debt to Assets [ 1.39% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 4.38K |
---|---|
min | 0% |
max | 116.6% |
average | 26.32% |
median | 21.04% |
std | 24.51% |